Jane Street
LABD icon

Jane Street’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Jane Street’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Buy
61,389
+28,929
+89% +$548K ﹤0.01% 6491
2025
Q4 		$684K Buy
32,460
+1,010
+3% +$27.4K ﹤0.01% 7019
2025
Q3 		$1.27M Sell
31,450
-2,242
-7% -$130K ﹤0.01% 5810
2025
Q2 		$2.52M Buy
33,692
+19,240
+133% +$1.7M ﹤0.01% 4050
2025
Q1 		$1.36M Sell
14,452
-730
-5% -$53.4K ﹤0.01% 5010
2024
Q4 		$1.1M Buy
15,182
+7,051
+87% +$431K ﹤0.01% 5195
2024
Q3 		$475K Sell
8,131
-12,224
-60% -$743K ﹤0.01% 7281
2024
Q2 		$1.49M Buy
20,355
+5,401
+36% +$456K ﹤0.01% 5019
2024
Q1 		$1.09M Buy
+14,954
New +$1.25M ﹤0.01% 5257
2023
Q4 		– Sell
-27,274
Closed -$5.62M – 9528
2023
Q3 		$5.62M Buy
27,274
+7,210
+36% +$1.17M ﹤0.01% 2452
2023
Q2 		$2.88M Sell
20,064
-6,337
-24% -$947K ﹤0.01% 3561
2023
Q1 		$5.44M Buy
+26,401
New +$4.48M ﹤0.01% 2330
2022
Q4 		– Sell
-29,769
Closed -$7.13M – 9668
2022
Q3 		$7.13M Buy
29,769
+13,378
+82% +$3.11M ﹤0.01% 2099
2022
Q2 		$6.38M Buy
16,391
+5,653
+53% +$2.83M ﹤0.01% 2314
2022
Q1 		$3.77M Buy
10,738
+693
+7% +$272K ﹤0.01% 3521
2021
Q4 		$2.59M Buy
10,045
+1,592
+19% +$366K ﹤0.01% 3970
2021
Q3 		$1.8M Buy
8,453
+1,949
+30% +$415K ﹤0.01% 4691
2021
Q2 		$1.25M Buy
+6,504
New +$1.46M ﹤0.01% 5325
2021
Q1 		– Sell
-5,872
Closed -$1.14M – 9380
2020
Q4 		$1.48M Sell
5,872
-408
-6% -$156K ﹤0.01% 4020
2020
Q3 		$3.75M Buy
6,280
+5,828
+1,289% +$3.76M ﹤0.01% 2186
2020
Q2 		$313K Buy
452
+247
+120% +$310K ﹤0.01% 5771
2020
Q1 		$577K Sell
205
-133
-39% -$379K ﹤0.01% 3468
2019
Q4 		$835K Sell
338
-425
-56% -$1.51M ﹤0.01% 3014
2019
Q3 		$3.87M Buy
763
+396
+108% +$1.63M 0.01% 1186
2019
Q2 		$1.32M Buy
367
+127
+53% +$535K ﹤0.01% 2328
2019
Q1 		$881K Buy
240
+150
+167% +$727K ﹤0.01% 2963
2018
Q4 		$768K Sell
90
-37
-29% -$271K ﹤0.01% 2925
2018
Q3 		$618K Buy
127
+73
+135% +$352K ﹤0.01% 3355
2018
Q2 		$282K Sell
54
-40
-43% -$243K ﹤0.01% 4194
2018
Q1 		$687K Buy
+94
New +$653K ﹤0.01% 3114
2017
Q4 		– Sell
-37
Closed -$368K – 4924
2017
Q3 		$336K Buy
37
+30
+429% +$362K ﹤0.01% 3552
2017
Q2 		$95K Sell
7
-2
-22% -$38.4K ﹤0.01% 4169
2017
Q1 		$198K Sell
9
-17
-65% -$420K ﹤0.01% 3870
2016
Q4 		$977K Buy
26
+7
+37% +$269K ﹤0.01% 2112
2016
Q3 		$653K Buy
19
+10
+111% +$468K ﹤0.01% 2467
2016
Q2 		$627K Sell
9
-7
-44% -$564K ﹤0.01% 2521
2016
Q1 		$1.74M Buy
16
+1
+7% +$128K 0.01% 1315
2015
Q4 		$949K Buy
15
+11
+275% +$841K 0.01% 1788
2015
Q3 		$509K Sell
4
-1
-20% -$70.8K ﹤0.01% 2285
2015
Q2 		$296K Buy
+5
New +$357K ﹤0.01% 2838

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Jane Street's LABD Position: Q1 2026 in Review

Jane Street increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 89% in Q1 2026, buying an estimated $548K and bringing the position to 61,389 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #6491.

Jane Street first reported a position in LABD in Q2 2015 and has held it in 40 quarters since. The position peaked at $7.13M in Q3 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Jane Street held 61,389 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $1M as of Q1 2026.
  • Jane Street bought 28,929 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $548K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6491 holding.
  • Jane Street first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2015 and has held it in 40 quarters since.
  • Jane Street's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $7.13M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.